Relapsing Polychondritis Overview

Save information for later
Sign Up

Learn About Relapsing Polychondritis

What is the definition of Relapsing Polychondritis?
Relapsing polychondritis (RP) is characterized by recurrent swelling and inflammation of cartilage and other tissues throughout the body. Cartilage is a tough but flexible tissue that covers the ends of bones at a joint and gives shape and support to other parts of the body. Other parts of the body that may be involved are the airways (trachea), costal (rib) cartilage, eyes, heart, vascular (veins) system, skin, kidney, and nervous system. The signs and symptoms vary from person to person depending on which parts of the body are affected. The exact underlying cause of RP is unknown. There are thought to be genetic and other unknown factors involved. RP often occurs along with autoimmune conditions. Diagnosis is based on the symptoms and clinical examination. Other more common conditions may need to be excluded before RP can be diagnosed.
What are the alternative names for Relapsing Polychondritis?
  • Relapsing polychondritis
  • Chronic atrophic polychondritis
  • Polychondropathia
  • Recurrent polychondritis
Who are the top Relapsing Polychondritis Local Doctors?
Elite in Relapsing Polychondritis
Jun Shimizu
Elite in Relapsing Polychondritis
Jun Shimizu
Tokyo, JP 

Jun Shimizu practices in Tokyo, Japan. Mr. Shimizu and is rated as an Elite expert by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Relapsing Polychondritis, Myositis, Inclusion Body Myositis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Elite in Relapsing Polychondritis
Laurent Arnaud
Elite in Relapsing Polychondritis
Laurent Arnaud
Strasbourg, FR 

Laurent Arnaud practices in Strasbourg, France. Mr. Arnaud and is rated as an Elite expert by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Relapsing Polychondritis, Systemic Lupus Erythematosus (SLE), Erdheim-Chester Disease, Cutaneous Lupus Erythematosus (CLE), and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Relapsing Polychondritis
Nathalie Chalumeau-Costedoat
Elite in Relapsing Polychondritis
Nathalie Chalumeau-Costedoat
Paris, FR 

Nathalie Chalumeau-Costedoat practices in Paris, France. Ms. Chalumeau-Costedoat and is rated as an Elite expert by MediFind in the treatment of Relapsing Polychondritis. Her top areas of expertise are Congenital Heart Block, Relapsing Polychondritis, Systemic Lupus Erythematosus (SLE), Kidney Transplant, and Splenectomy.

View All Doctors
What are the latest Relapsing Polychondritis Clinical Trials?
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Enrollment Status: Recruiting
Publish Date: June 04, 2025

Background: - Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Enrollment Status: Recruiting
Publish Date: March 12, 2025
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: Relapsing polychondritis (RP) is a rare, systemic autoimmune disorder characterized by episodic inflammation of cartilaginous structures. The goal of this clinical trial is to learn if drug Upadacitinib works to treat relapsing polychondritis in adults. It will also learn about the safety of drug Upadacitinib. The main questions it aims to answer are: * Does drug Upadacitinib reduce the disease ac...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center